Skip to main content

Juno Therapeutics, Inc. v. Kite Pharma, Inc.

Certiorari Denied

Petition for certiorari denied on November 7, 2022.

Docket No.21-1566
Op. BelowFed. Cir.

Issue

Whether the adequacy of the "written description of [an] invention" is measured by the statutory standard of "in such full, clear, concise, and exact terms as to enable any person skilled in the art to make and use the same" in 35 U.S.C. § 112(a), or by the Federal Circuit"s test that the "written description of the invention" must demonstrate the inventor"s "possession" of "the full scope of the claimed invention" including all "known and unknown" variations of each component.

Proceedings & orders timeline

Welcome to SCOTUSblog

Tell us a bit about yourself so we can tailor what you see. You can update these any time in your account.